- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2008
- Public Summary Document (PSD) November 2008 PBAC Meeting - PDF
Panitumumab – November 2008
Panitumumab, concentrated solution for infusion, 20 mg per mL, 5 mL, Vectibix®, November 2008
Last updated
20 March 2009